Two Québec-based companies are joining forces to deploy innovative solutions focused on patient autonomy and the resilience of our healthcare system.

This alliance accelerates access to IV fluids and dialysate production through existing facilities capable of producing up to 200,000 liters per day, already compliant with Health Canada and FDA requirements.

By combining two complementary technologies, the partnership brings care closer to patients with kidney failure and strengthens the supply of IV and dialysis solutions across Canada.

The result is direct benefits for patients and clinical teams, along with a meaningful reduction in our healthcare system’s fragile dependence on imported life-saving solutions.